Cite
HARVARD Citation
Glockzin, G. et al. (n.d.). Treatment‐related morbidity and toxicity of CRS and oxaliplatin‐based HIPEC compared to a mitomycin and doxorubicin‐based HIPEC protocol in patients with peritoneal carcinomatosis: A matched‐pair analysis. Journal of surgical oncology. 107 (6), pp. 574-578. [Online].